Valeant Names Perrigo's Papa as CEO to Lead TurnaroundBy and
Drugmaker has been searching for a new CEO since March
Papa joined Perrigo in 2006, fended off hostile bid from Mylan
Valeant Pharmaceuticals International Inc. hired Perrigo Co. CEO Joseph Papa as its new chief executive officer and chairman, tasking him with turning around an embattled drugmaker that has faced multiple setbacks over the past months.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.